Andreas Matouschek

Last updated
Andreas Matouschek
Born
Germany
NationalityAmerican
Alma mater Cambridge University (PhD, 1988-1992)
Known for Protein unfolding
Proteasome
AwardsEly Lilly Award in Biological Chemistry (2003)
Scientific career
Fields Biochemistry
Biophysics
Institutions The University of Texas at Austin (2012-present)
Northwestern University (1996-2012)
University of Basel (1993-1996)
University of Cambridge (1988-1993)
Doctoral advisor Sir Alan Fersht
Website www.matouscheklab.org

Andreas Matouschek is a biochemist at The University of Texas at Austin, where he is a professor in the College of Natural Sciences. [1] His graduate work with Alan Fersht resulted in the seminal application of phi-value analysis to the study of barnase, a bacterial RNAse used in many protein folding studies. [2] Development of phi value analysis in combination with extensive protein engineering enabled an understanding of the kinetic intermediates during protein folding of barnase. In subsequent postdoctoral work at the University of Basel, he studied how mitochondria refold proteins after importing them. In 1996, he moved to Northwestern University. In 2012, he moved to The University of Texas at Austin.

Contents

Matouschek currently studies the proteasome, the degradation machinery of eukaryotic cells, and the mechanisms by which the proteasome is able to unfold and translocate proteins. [3]

Scientific career

Cambridge (1988-1993)

At Cambridge, Matouschek was a graduate student under Sir Alan Fersht from 1988 to 1992. In 1989, he pioneered the use of phi value analysis in combination with protein engineering in order to study the transition state of the bacterial protein barnase. [4] By engineering mutations in carefully chosen portions of barnase and computing the ratio between the energetic destabilization introduced by a mutation in the transition state of barnase versus that of the same mutation to barnase's native state, he was able to gain insight about the transition state of barnase and its folding pathway. After receiving his PhD in 1992, Matouschek continued his work with Fersht, serving as a research fellow at the Centre for Protein Engineering for an additional year.

University of Basel (1993-1996)

At the University of Basel, Matoschek was a postdoctorate fellow under Gottfried (Jeff) Schatz.

Northwestern University (1996-2012)

The University of Texas at Austin (2012-present)

Matouschek was recruited to The University of Texas at Austin in 2012.

Related Research Articles

<span class="mw-page-title-main">Stop codon</span> Codon that marks the end of a protein-coding sequence

In molecular biology, a stop codon is a codon that signals the termination of the translation process of the current protein. Most codons in messenger RNA correspond to the addition of an amino acid to a growing polypeptide chain, which may ultimately become a protein; stop codons signal the termination of this process by binding release factors, which cause the ribosomal subunits to disassociate, releasing the amino acid chain.

<span class="mw-page-title-main">Structural biology</span> Study of molecular structures in biology

Structural biology is a field that is many centuries old which, and as defined by the Journal of Structural Biology, deals with structural analysis of living material at every level of organization. Early structural biologists throughout the 19th and early 20th centuries were primarily only able to study structures to the limit of the naked eye's visual acuity and through magnifying glasses and light microscopes.

<span class="mw-page-title-main">Ubiquitin</span> Regulatory protein

Ubiquitin is a small regulatory protein found in most tissues of eukaryotic organisms, i.e., it is found ubiquitously. It was discovered in 1975 by Gideon Goldstein and further characterized throughout the late 1970s and 1980s. Four genes in the human genome code for ubiquitin: UBB, UBC, UBA52 and RPS27A.

<span class="mw-page-title-main">Protein folding</span> Change of a linear protein chain to a 3D structure

Protein folding is the physical process by which a protein chain is translated into its native three-dimensional structure, typically a "folded" conformation, by which the protein becomes biologically functional. Via an expeditious and reproducible process, a polypeptide folds into its characteristic three-dimensional structure from a random coil. Each protein exists first as an unfolded polypeptide or random coil after being translated from a sequence of mRNA into a linear chain of amino acids. At this stage, the polypeptide lacks any stable three-dimensional structure. As the polypeptide chain is being synthesized by a ribosome, the linear chain begins to fold into its three-dimensional structure.

<span class="mw-page-title-main">Chaperone (protein)</span> Proteins assisting in protein folding

In molecular biology, molecular chaperones are proteins that assist the conformational folding or unfolding of large proteins or macromolecular protein complexes. There are a number of classes of molecular chaperones, all of which function to assist large proteins in proper protein folding during or after synthesis, and after partial denaturation. Chaperones are also involved in the translocation of proteins for proteolysis.

<span class="mw-page-title-main">Alan Fersht</span> British chemist

Sir Alan Roy Fersht is a British chemist at the MRC Laboratory of Molecular Biology, Cambridge, and an Emeritus Professor in the Department of Chemistry at the University of Cambridge. He was Master of Gonville and Caius College, Cambridge from 2012 to 2018. He works on protein folding, and is sometimes described as a founder of protein engineering.

<span class="mw-page-title-main">Robert Huber</span> German biochemist and Nobel laureate (born 1937)

Robert Huber is a German biochemist and Nobel laureate. known for his work crystallizing an intramembrane protein important in photosynthesis and subsequently applying X-ray crystallography to elucidate the protein's structure.

<span class="mw-page-title-main">Luria–Delbrück experiment</span>

The Luria–Delbrück experiment (1943) demonstrated that in bacteria, genetic mutations arise in the absence of selective pressure rather than being a response to it. Thus, it concluded Darwin's theory of natural selection acting on random mutations applies to bacteria as well as to more complex organisms. Max Delbrück and Salvador Luria won the 1969 Nobel Prize in Physiology or Medicine in part for this work.

<span class="mw-page-title-main">Conserved sequence</span> Similar DNA, RNA or protein sequences within genomes or among species

In evolutionary biology, conserved sequences are identical or similar sequences in nucleic acids or proteins across species, or within a genome, or between donor and receptor taxa. Conservation indicates that a sequence has been maintained by natural selection.

Phi value analysis, analysis, or -value analysis is an experimental protein engineering technique for studying the structure of the folding transition state of small protein domains that fold in a two-state manner. The structure of the folding transition state is hard to find using methods such as protein NMR or X-ray crystallography because folding transitions states are mobile and partly unstructured by definition. In -value analysis, the folding kinetics and conformational folding stability of the wild-type protein are compared with those of point mutants to find phi values. These measure the mutant residue's energetic contribution to the folding transition state, which reveals the degree of native structure around the mutated residue in the transition state, by accounting for the relative free energies of the unfolded state, the folded state, and the transition state for the wild-type and mutant proteins.

<span class="mw-page-title-main">Barnase</span> Bacterial ribonuclease protein

Barnase (a portmanteau of "BActerial" "RiboNucleASE") is a bacterial protein that consists of 110 amino acids and has ribonuclease activity. It is synthesized and secreted by the bacterium Bacillus amyloliquefaciens, but is lethal to the cell when expressed without its inhibitor barstar. The inhibitor binds to and occludes the ribonuclease active site, preventing barnase from damaging the cell's RNA after it has been synthesized but before it has been secreted. The barnase/barstar complex is noted for its extraordinarily tight protein-protein binding, with an on-rate of 108s−1M−1.

Tyrosine—tRNA ligase, also known as tyrosyl-tRNA synthetase is an enzyme that is encoded by the gene YARS. Tyrosine—tRNA ligase catalyzes the chemical reaction

<span class="mw-page-title-main">Valosin-containing protein</span>

Valosin-containing protein (VCP) or transitional endoplasmic reticulum ATPase also known as p97 in mammals and CDC48 in S. cerevisiae, is an enzyme that in humans is encoded by the VCP gene. The TER ATPase is an ATPase enzyme present in all eukaryotes and archaebacteria. Its main function is to segregate protein molecules from large cellular structures such as protein assemblies, organelle membranes and chromatin, and thus facilitate the degradation of released polypeptides by the multi-subunit protease proteasome.

<span class="mw-page-title-main">UBQLN2</span> Protein-coding gene in the species Homo sapiens

Ubiquilin-2 is a protein that in humans is encoded by the UBQLN2 gene.

<span class="mw-page-title-main">Protein aggregation</span> Accumulation of clumps of misfolded or disordered proteins

In molecular biology, protein aggregation is a phenomenon in which intrinsically-disordered or mis-folded proteins aggregate either intra- or extracellularly. Protein aggregates have been implicated in a wide variety of diseases known as amyloidoses, including ALS, Alzheimer's, Parkinson's and prion disease.

<span class="mw-page-title-main">Robustness (evolution)</span> Persistence of a biological trait under uncertain conditions

In evolutionary biology, robustness of a biological system is the persistence of a certain characteristic or trait in a system under perturbations or conditions of uncertainty. Robustness in development is known as canalization. According to the kind of perturbation involved, robustness can be classified as mutational, environmental, recombinational, or behavioral robustness etc. Robustness is achieved through the combination of many genetic and molecular mechanisms and can evolve by either direct or indirect selection. Several model systems have been developed to experimentally study robustness and its evolutionary consequences.

Victor Muñoz is a biochemist whose focus has been on protein folding and design. He provided experimental evidence for a mechanism of protein folding called as "downhill folding". He has pioneered various computational and experimental techniques to study this mechanism as well as to gain insights into the general process of protein folding.

The MRC Centre for Protein Engineering was a pioneering research unit in Cambridge, England, with a main focus on the structure, stability and activity of proteins and engineering of antibodies.

<span class="mw-page-title-main">Jane Clarke (scientist)</span> English biochemist and academic

Jane Clarke is an English biochemist and academic. Since October 2017, she has served as President of Wolfson College, Cambridge. She is also Professor of Molecular Biophysics, a Wellcome Trust Senior Research Fellow in the Department of Chemistry at the University of Cambridge. She was previously a Fellow of Trinity Hall, Cambridge.

Brian Selby Hartley FRS was a British biochemist. He was Professor of Biochemistry at Imperial College London from 1974 to 1991.

References

  1. "Matouschek, Andreas (CNS Faculty Profiles)". The University of Texas at Austin.
  2. Matouschek, Andreas; Kellis, James T.; Serrano, Luis; Bycroft, Mark; Fersht, Alan R. (1990). "Transient folding intermediates characterized by protein engineering". Nature. 346 (6283): 440–5. Bibcode:1990Natur.346..440M. doi:10.1038/346440a0. PMID   2377205. S2CID   4316156.
  3. Schrader, Erin K; Harstad, Kristine G; Matouschek, Andreas (2009). "Targeting proteins for degradation". Nature Chemical Biology. 5 (11): 815–22. doi:10.1038/nchembio.250. PMC   4228941 . PMID   19841631.
  4. Matouschek, A; Kellis, JT; Serrano, L; Fersht, AR (1989). "Mapping the transition state and pathway of protein folding by protein engineering". Nature. 340 (6229): 122–6. Bibcode:1989Natur.340..122M. doi:10.1038/340122a0. PMID   2739734. S2CID   4302226.